Start: 11 Nov 2021, 14:15
End: 11 Nov 2021, 15:15

Chair: Dr Eileen Parkes, University of Oxford, UK

This session is jointly organised with the British Society for Immunology.


Abstract title: Efficacy of avelumab + axitinib (A + Ax) vs sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): extended follow-up results from JAVELIN Renal 101
Presenting author: James Larkin

Abstract title: Comprehensive evaluation of risk factors associated with immune checkpoint blockade-induced hepatitis
Presenting author: Colin Lee

Abstract title: Harnessing liver-resident gamma delta T cells for immunotherapy of hepatocellular carcinoma
Presenting author: Nekisa Zakeri

Session labels:

Allied Health Professionals Bladder and renal Clinical trials Clinicians Liver Living with and beyond cancer Nurses Patient experts Proffered papers Scientists Students Trainees / Early career researchers Treatment